Related Experiment Video
Updated: Mar 25, 2026

09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
16.1K
[Social Cognitive Impairment in Myotonic Dystrophy Type 1].
1Department of Informatics, Faculty of Informatics, Tokyo University of Information Sciences.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|February 14, 2016
Summary
Myotonic dystrophy type 1 (DM 1) patients show impaired social cognition, specifically in recognizing emotions and understanding others' mental states. These deficits may stem from brain abnormalities linked to DM 1.
Area of Science:
- Neurology
- Genetics
- Psychology
Context:
- Myotonic dystrophy type 1 (DM 1) is a genetic disorder affecting multiple systems, including the brain.
- DM 1 is frequently associated with developmental and behavioral disorders, such as autism spectrum disorder (ASD).
- Autistic traits in DM 1 may be linked to social cognitive deficits.
Purpose:
- To investigate social cognitive functions in DM 1 patients, focusing on facial emotion recognition and theory of mind.
- To determine if deficits in these areas are attributable to visual impairment or lexical comprehension issues.
- To explore potential neurological underpinnings of social cognitive dysfunction in DM 1.
Summary:
- Patients with DM 1 exhibited reduced sensitivity to disgust and anger facial expressions compared to controls.
- DM 1 patients demonstrated impairments in theory of mind tasks, including the "Reading the Mind in the Eyes" test and faux pas recognition.
- These social cognitive deficits were not explained by visual acuity or language comprehension abilities.
Impact:
- Findings suggest that cerebral atrophy and white matter abnormalities in specific brain regions (temporal, frontal, insular cortex) contribute to social cognitive dysfunction in DM 1.
- This dysfunction may underlie the observed behavioral and communication disorders in individuals with DM 1.
- Highlights the need for targeted interventions addressing social cognition in DM 1 management.
Related Concept Videos
Disorders of the Skeletal Muscle
2.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Satellite Stem Cells and Muscular Dystrophy
2.5K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K
Autism Spectrum Disorder
1.7K
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.7K
Cross-bridge Cycle
124.7K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
124.7K
Myasthenia Gravis: Overview and Treatment
3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
Myasthenia Gravis: Diagnostic Tests
3.1K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.1K

